Life cycle of PharmaceuticalManufacturing<br />Energy<br />Water<br />Air<br />Solid Waste<br />Transportation<br />
Energy<br />Healthcare organizations spend over $6.5 billion on energy each year.<br />http://www.energystar.gov/ia/busine...
Water<br />In 2005, the average pharmaceutical company used 22 million cubic meters of freshwater<br />17 (59%)  which is ...
Air<br />The heavy use of solvents in drug research, development, and manufacturing results in the emission of Hazardous A...
C02 and Pharm Footprint<br />Procurement forms 60% of the emissions for which National Health Service England is responsib...
NHS Recommendation	<br />Examine usage/wastage of pharmaceuticals manufactuers<br />Work with key manufacturers on lowerin...
Solid Waste<br />More than 80% of the hazardous waste in drug development consists of solvents that are used in production...
Transportation <br />Transportation of pharmaceutical by manufacturers is equivalent to the impact of transportation by pa...
Sustainability Initiatives<br />Sustainability initiatives are an essential aspect of most of the major companies.  <br />...
3.2. Life Cycle Dynamics (Kreisberg)
Upcoming SlideShare
Loading in …5
×

3.2. Life Cycle Dynamics (Kreisberg)

423 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
423
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

3.2. Life Cycle Dynamics (Kreisberg)

  1. 1. Life cycle of PharmaceuticalManufacturing<br />Energy<br />Water<br />Air<br />Solid Waste<br />Transportation<br />
  2. 2. Energy<br />Healthcare organizations spend over $6.5 billion on energy each year.<br />http://www.energystar.gov/ia/business/challenge/learn_more/Healthcare.pdf<br />Pharmaceutical manufacturing plants in the U.S. spend nearly $1 billion each year for the fuel and electricity they need to keep their facilities running.<br />Improving Energy Efficiency in Pharmaceutical Manufacturing Operations<br />Authors: Galitsky, Christina; Chang, Sheng-chieh; Worrell, Ernst; Masanet, Eric2006-06-01 LBNL-60288 http://ies.lbl.gov/node/351<br />
  3. 3. Water<br />In 2005, the average pharmaceutical company used 22 million cubic meters of freshwater<br />17 (59%) which is sourced mainly from municipal water supplies <br />13 (40%) wells or boreholes<br />Water consumption has been targeted by Pharma for conservation practices. Programs are continuing to reduce consumption<br />
  4. 4. Air<br />The heavy use of solvents in drug research, development, and manufacturing results in the emission of Hazardous Air Pollutants (HAPs), such as volatile organic compounds (VOCs). <br />Theemissions of VOCs can give rise to ground level ozone in the presence of UV light, which has adverse effects on human and plant life. <br />In order to curb air pollution, the pharmaceutical industry is increasing the reuse and recycling of solvents during drug manufacturing and installing VOC abatement equipment. <br />
  5. 5. C02 and Pharm Footprint<br />Procurement forms 60% of the emissions for which National Health Service England is responsible; within the procurement sector pharmaceuticals are the largest subsector, making up 22% of total emissions. <br />Emissions from procurement of pharmaceuticals make up one fifth of the total CO2 emissions for NHS England, and are comparable to emissions from either building energy use or travel sectors.<br />
  6. 6. NHS Recommendation <br />Examine usage/wastage of pharmaceuticals manufactuers<br />Work with key manufacturers on lowering GHG emission<br />Study the carbon intensities by world region for generic and R&D based medicines <br />Investigate alternative models of care which may be less drug intensive<br />
  7. 7. Solid Waste<br />More than 80% of the hazardous waste in drug development consists of solvents that are used in production processes, and a daunting number of regulations guide and restrict the way hazardous waste is handled.<br />Solid waste trends for many of the larger pharmaceutical companies continue to show reductions in quantities needing to be incinerated or disposed of in landfills<br />
  8. 8. Transportation <br />Transportation of pharmaceutical by manufacturers is equivalent to the impact of transportation by patients and staff for the entire health care sector. <br />Pharmaceuticals developed overseas have a far greater CO2 footprint due to lower standards many developing countries. <br />
  9. 9. Sustainability Initiatives<br />Sustainability initiatives are an essential aspect of most of the major companies. <br />Abbott Labs<br />Johnson & Johnson <br />Pfizer <br />GlaxoSmithKline <br />Roche <br />All have initiative well under way <br />http://www.sustainability-index.com/<br />

×